Niagen Bioscience
Price & Volume
Stats
See more52W Range | $3.57-$14.69 |
Market Cap | $305.8M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $130.4M |
Revenue Growth (YoY) | 3.3% |
Gross Profit (12 Mos) | $83.8M |
Diluted EPS | $0.21 |
News
See moreYahoo Finance • 3 months ago
U.S. expands Latin America drug fight with joint operation in Ecuador
Yahoo Finance • 3 months ago
Niagen Bioscience targets 10–15% revenue growth for 2026 while expanding injectable product line
Yahoo Finance • 3 months ago
Niagen Bioscience GAAP EPS of $0.05 beats by $0.03, revenue of $33.84M beats by $2.14M
Yahoo Finance • 3 months ago
Promising Penny Stocks To Consider In February 2026
About
CEO | Mr. Robert N. Fried |
CFO | Mr. Ozan Pamir C.F.A. |
Address | 10900 Wilshire Blvd, Los Angeles, CA, United States, 90024 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 117 |